$AGL Income Statement | Understand Stock

$AGL

$90.34 +$0.63 (0.7%) Close

$AGL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenues
Medical Services
Other Operating Revenue
Other Operating
Medical services revenue
Other operating revenue
Total revenues

Expenses:
Medical services expense
Other medical expenses
Expenses
Medical Services
Other Operating
Medical services revenue
Other operating revenue
General and administrative
Depreciation and amortization
Impairments
Total expenses

Income (loss) from operations
Other income (expense):
Income (loss) from equity method investments
Other income (expense), net
Gain (loss) on lease terminations
Interest expense
Income (loss) before income taxes
Income tax benefit (expense)
Income (loss) from continuing operations
Discontinued operations:
Impairments
Income (loss) before gain (loss) on sales
Gain (loss) and adjustments on sales of assets, net
Income tax benefit (expense)
Total discontinued operations

Net income (loss)
Noncontrolling interests’ share in (earnings) loss
Net income (loss) attributable to common shares
Continuing operations
Discontinued operations
Weighted average shares outstanding, basic and diluted
Net income (loss) per common share, basic and diluted
Continuing operations basic (in dollars per share)
Continuing operations diluted (in dollars per share)
Discontinued operations basic (in dollars per share)
Discontinued operations diluted (in dollars per share)
Weighted average shares outstanding, basic (in shares)
Weighted average shares outstanding, diluted (in shares)

Comments